查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387490

萤光原位杂交 (FISH) 市场报告：2030 年趋势、预测与竞争分析

Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

萤光原位杂交 (FISH) 趋势和预测

到 2030 年，全球萤光原位杂交 (FISH) 市场预计将达到 18.4 亿美元，2024 年至 2030 年年复合成长率为 7.6%。该市场的主要驱动因素是癌症和遗传疾病患者数量的增加以及 FISH 产品的持续进步。全球萤光原位杂交 (FISH) 市场的未来前景广阔，在癌症研究、基因研究、感染疾病和个人化医疗市场中充满机会。

萤光原位杂交 (FISH) 市场洞察

Lucintel 预测，在预测期内，消耗品仍将是最大的细分市场。

在这个市场中，由于癌症盛行率的增加和政府对癌症研究的支持不断增加，预计癌症研究将出现最高的增长。

由于乳癌和感染疾病治疗研发投资的增加，预计北美在预测期内仍将是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球萤光原位杂交（FISH）市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球萤光原位杂交 (FISH) 市场趋势 (2018-2023) 和预测 (2024-2030)
  • 按产品类型分類的全球萤光原位杂交 (FISH) 市场
    • 消耗品
    • 装置
    • 软体
  • 按技术分類的全球萤光原位杂交 (FISH) 市场
    • DNA萤光原位杂交
    • RNA萤光原位杂交
    • PNA萤光原位杂交
    • 其他的
  • 全球萤光原位杂交 (FISH) 市场（按应用）
    • 癌症研究
    • 基因研究
    • 感染疾病
    • 个人化医疗
    • 其他的
  • 以最终用途分類的全球萤光原位杂交 (FISH) 市场
    • 医院和诊所
    • 诊断实验室
    • 製药和生物技术公司
    • 受託研究机构
    • 学术研究所
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球萤光原位杂交 (FISH) 市场（按地区）
  • 北美萤光原位杂交（FISH）市场
  • 欧洲萤光原位杂交（FISH）市场
  • 亚太地区萤光原位杂交 (FISH) 市场
  • 其他地区萤光原位杂交（FISH）市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品类型分類的全球萤光原位杂交 (FISH) 市场成长机会
    • 全球萤光原位杂交 (FISH) 市场成长机会（按技术）
    • 全球萤光原位杂交 (FISH) 市场成长机会（按应用）
    • 全球萤光原位杂交 (FISH) 市场成长机会（按最终用途）
    • 全球萤光原位杂交 (FISH) 市场成长机会（按地区）
  • 全球萤光原位杂交 (FISH) 市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球萤光原位杂交 (FISH) 市场产能扩张
    • 全球萤光原位杂交 (FISH) 市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific
简介目录

Fluorescent in Situ Hybridization (FISH) Trends and Forecast

The future of the global fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets. The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $1.84 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

A more than 150-page report is developed to help in your business decisions.

Fluorescent in Situ Hybridization (FISH) by Segment

The study includes a forecast for the global fluorescent in situ hybridization (FISH) by product type, technology, application, end use, and region.

Fluorescent in Situ Hybridization (FISH) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Instrument
  • Software

Fluorescent in Situ Hybridization (FISH) Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • DNA Fluorescent in Situ Hybridization
  • RNA Fluorescent in Situ Hybridization
  • PNA Fluorescent in Situ Hybridization
  • Others

Fluorescent in Situ Hybridization (FISH) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer Research
  • Genetic Research
  • Infectious Disease
  • Personalized Medicine
  • Others

Fluorescent in Situ Hybridization (FISH) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Pharmaceuticals & Biotechnology Companies
  • Contract Research Organisations
  • Academic & Research Organisations
  • Others

Fluorescent in Situ Hybridization (FISH) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Fluorescent in Situ Hybridization (FISH) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies fluorescent in situ hybridization (FISH) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fluorescent in situ hybridization (FISH) companies profiled in this report include-

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific

Fluorescent in Situ Hybridization (FISH) Market Insights

Lucintel forecasts that consumables will remain the largest segment over the forecast period.

Within this market, cancer research is expected to witness the highest growth due to increasing prevalence of cancer and rising government support for cancer research.

North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Features of the Global Fluorescent in Situ Hybridization (FISH) Market

Market Size Estimates: Fluorescent in situ hybridization (FISH) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Fluorescent in situ hybridization (FISH) market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Fluorescent in situ hybridization (FISH) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the fluorescent in situ hybridization (FISH) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fluorescent in situ hybridization (FISH) market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the fluorescent in situ hybridization (FISH) market size?

Answer: The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $1.84 billion by 2030.

Q2. What is the growth forecast for fluorescent in situ hybridization (FISH) market?

Answer: The global fluorescent in situ hybridization (FISH) market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the fluorescent in situ hybridization (FISH) market?

Answer: The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

Q4. What are the major segments for fluorescent in situ hybridization (FISH) market?

Answer: The future of the fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets.

Q5. Who are the key fluorescent in situ hybridization (FISH) market companies?

Answer: Some of the key fluorescent in situ hybridization (FISH) companies are as follows:

  • Abnova Corporation
  • Agilent Technologies
  • Biocare Medical
  • Biodot
  • F. Hoffmann-LA Roche
  • Genemed Technologies
  • Merck
  • PERKINELMER
  • Qiagen
  • Thermo Fisher Scientific

Q6. Which fluorescent in situ hybridization (FISH) market segment will be the largest in future?

Answer: Lucintel forecasts that consumables will remain the largest segment over the forecast period.

Q7. In fluorescent in situ hybridization (FISH) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the fluorescent in situ hybridization (FISH) market by product type (consumables, instrument, and software), technology (DNA fluorescent in situ hybridization, RNA fluorescent in situ hybridization, PNA fluorescent in situ hybridization, and others), application (cancer research, genetic research, infectious disease, personalized medicine, and others), end use (hospitals & clinics, diagnostic laboratories, pharmaceuticals & biotechnology companies, contract research organisations, academic & research organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Fluorescent in Situ Hybridization (FISH) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Fluorescent in Situ Hybridization (FISH) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Fluorescent in Situ Hybridization (FISH) Market by Product Type
    • 3.3.1: Consumables
    • 3.3.2: Instrument
    • 3.3.3: Software
  • 3.4: Global Fluorescent in Situ Hybridization (FISH) Market by Technology
    • 3.4.1: DNA Fluorescent in Situ Hybridization
    • 3.4.2: RNA Fluorescent in Situ Hybridization
    • 3.4.3: PNA Fluorescent in Situ Hybridization
    • 3.4.4: Others
  • 3.5: Global Fluorescent in Situ Hybridization (FISH) Market by Application
    • 3.5.1: Cancer Research
    • 3.5.2: Genetic Research
    • 3.5.3: Infectious Disease
    • 3.5.4: Personalized Medicine
    • 3.5.5: Others
  • 3.6: Global Fluorescent in Situ Hybridization (FISH) Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Diagnostic Laboratories
    • 3.6.3: Pharmaceuticals & Biotechnology Companies
    • 3.6.4: Contract Research Organisations
    • 3.6.5: Academic & Research Organisations
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Fluorescent in Situ Hybridization (FISH) Market by Region
  • 4.2: North American Fluorescent in Situ Hybridization (FISH) Market
    • 4.2.2: North American Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.3: European Fluorescent in Situ Hybridization (FISH) Market
    • 4.3.1: European Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.3.2: European Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.4: APAC Fluorescent in Situ Hybridization (FISH) Market
    • 4.4.1: APAC Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.4.2: APAC Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others
  • 4.5: ROW Fluorescent in Situ Hybridization (FISH) Market
    • 4.5.1: ROW Fluorescent in Situ Hybridization (FISH) Market by Product Type: Consumables, Instrument, and Software
    • 4.5.2: ROW Fluorescent in Situ Hybridization (FISH) Market by Application: Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Technology
    • 6.1.3: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Application
    • 6.1.4: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by End Use
    • 6.1.5: Growth Opportunities for the Global Fluorescent in Situ Hybridization (FISH) Market by Region
  • 6.2: Emerging Trends in the Global Fluorescent in Situ Hybridization (FISH) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Fluorescent in Situ Hybridization (FISH) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Fluorescent in Situ Hybridization (FISH) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abnova Corporation
  • 7.2: Agilent Technologies
  • 7.3: Biocare Medical
  • 7.4: Biodot
  • 7.5: F. Hoffmann-LA Roche
  • 7.6: Genemed Technologies
  • 7.7: Merck
  • 7.8: PERKINELMER
  • 7.9: Qiagen
  • 7.10: Thermo Fisher Scientific